Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral antibiotics after anal abscess drainage to reduce fistula formation
2019-001002-18Phase 3Active
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Feb 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in perianal abscess and anal fistula comparing Ciprofloxacin + metronidazole with Placebo (2 arms). Primary endpoint: Anal fistula presence. Started Feb 2021; status: active.
02
Drugs
ciprofloxacinmetronidazole
03
Conditions
perianal abscessanal fistula
Beyond the preview
Go deeper on 2019-001002-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001002-18.